Harvard Bioscience
HBIO
HBIO
91 hedge funds and large institutions have $14.5M invested in Harvard Bioscience in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 37 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
-4
Holders Change %
-4.21%
% of All Funds
1.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
10
Increased
22
Reduced
37
Closed
12
Calls
$5K
Puts
$4K
Net Calls
+$1K
Net Calls Change
+$50K
Top Buyers
| 1 |
AE
AMH Equity
Great Neck,
New York
|
+$502K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$148K |
| 3 |
RC
RBF Capital
San Francisco,
California
|
+$102K |
| 4 |
Renaissance Technologies
New York
|
+$98.4K |
| 5 |
Squarepoint
New York
|
+$96.3K |
